HCHaim Yosef Cohen

Haim Yosef Cohen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haim Yosef Cohen has a total of 164 co-authors. Here are the top co-authors by number of shared publications:

  • Batia Lerrer

    The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel

    8 shared publications
  • Yariv Kanfi

    Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan 5290002, Israel

    8 shared publications
  • Asael Roichman

    The Mina & Everard Goodman Faculty of Life Sciences, The Sagol Center for Healthy Human Longevity, Bar-Ilan University, Ramat-Gan, Israel

    4 shared publications
  • Asaf A. Gertler

    The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University

    4 shared publications
  • Noga Touitou

    The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel

    4 shared publications
  • Shoshana Naiman

    The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University

    4 shared publications

Latest Publications

  • Open Access

    SIRT6 overexpression counteracts chromatin aging in the male murine liver

    by Ron Nagar, Zacharia Schwartz, Almog Katz, Noga Touitou, Efrat Sharon, Kobi Tzdaka, Odeya Waner, Noam Shalev, Rotem Clo, Leah Weiss, et al.

    Aging is associated with detrimental changes in chromatin structure and gene expression, contributing to inflammation, metabolic decline and tissue dysfunction. SIRT6, a histone deacetylase, plays a key role in maintaining chromatin integrity and promoting longevity. Our multi-omics approach, combining ATAC-seq, methylome and RNA-seq shows that aging leads to increased chromatin accessibility in the male murine liver, accompanied by upregulation of inflammation and downregulation of metabolic pathways. Remarkably, SIRT6 overexpression reverses these changes in chromatin structure, reducing inflammation and enhancing metabolic function. Notably, ETS family members and liver-enriched transcription factors are enriched in regions with increased and reduced accessibility during aging, respectively. ChIP-seq shows that H3K9ac, but not H3K56ac, is associated with increased accessibility during aging, and that SIRT6 can reverse this effect. Furthermore, AAV-mediated SIRT6 overexpression in aged male mice demonstrates that SIRT6 not only slows age-related chromatin changes but can also reverse them, rejuvenating chromatin accessibility to a youthful state.


  • Open Access

    Sirt6 prevents the age-related decline of H 2 S through the control of one-carbon metabolism

    by Noga Touitou, Liat Nahum, Sarit Feldman-Trabelsi, Matan Y. Avivi, Miguel A. Aon, Shoshana Naiman, Moran Rathaus, Asaf A. Gertler, Asael Roichman, Lia Berkman Dvir, et al.

    Mice overexpressing Sirt6 or fed a caloric restriction (CR) diet live longer with improved health. CR increases Sirt6 levels, and its beneficial effects are mediated by the gasotransmitter H 2 S, a one-carbon pathway product. Yet, the role of this pathway in Sirt6-regulated longevity remains elusive. Here, we show that Sirt6 controls hepatic one-carbon metabolism, preventing the aging-dependent H 2 S reduction, and the elevation of the methyl donor, S-adenosylmethionine (SAM). Sirt6 downregulates Slc7a11 expression in an Sp1-dependent manner, decreasing cystine uptake and increasing Cgl H 2 S production activity. Additionally, comparative acetylome in old livers revealed Sirt6-related differential acetylation of most of the one-carbon enzymes. Specifically, Sirt6-dependent Matα1 K235 deacetylation reduces its SAM production activity and Cbs binding, thereby reducing its activation of Cbs-dependent H 2 S production. The net outcome is H 2 S and SAM levels as observed in young animals. Thus, we unveil a fundamental mechanism for the promotion of healthy longevity by Sirt6.


  • Open Access

    The mammalian longevity associated acetylome

    by S. Feldman-Trabelsi, N. Touitou, R. Nagar, Z. Schwartz, A. Michelson, S. Shaki, M. Y. Avivi, B. Lerrer, S. Snir, H. Y. Cohen

    Despite extensive studies at the genomic, transcriptomic and metabolomic levels, the underlying mechanisms regulating longevity are incompletely understood. Post-translational protein acetylation is suggested to regulate aspects of longevity. To further explore the role of acetylation, we develop the PHARAOH computational tool based on the 100-fold differences in longevity within the mammalian class. Analyzing acetylome and proteome data across 107 mammalian species identifies 482 and 695 significant longevity-associated acetylated lysine residues in mice and humans, respectively. These sites include acetylated lysines in short-lived mammals that are replaced by permanent acetylation or deacetylation mimickers, glutamine or arginine, respectively, in long-lived mammals. Conversely, glutamine or arginine residues in short-lived mammals are replaced by reversibly acetylated lysine in long-lived mammals. Pathway analyses highlight the involvement of mitochondrial translation, cell cycle, fatty acid oxidation, transsulfuration, DNA repair and others in longevity. A validation assay shows that substituting lysine 386 with arginine in mouse cystathionine beta synthase, to attain the human sequence, increases the pro-longevity activity of this enzyme. Likewise, replacing the human ubiquitin-specific peptidase 10 acetylated lysine 714 with arginine as in short-lived mammals, reduces its anti-neoplastic function. Overall, in this work we propose a link between the conservation of protein acetylation and mammalian longevity.


  • Longevity Nation—Enhancing Research, Development and Education for Healthy Longevity

    by I. Stambler, S. Lederman, S. J. Olshansky, H. Y. Cohen, B. Schumacher, S. Greenfield, V. Krizhanovsky, M. Grunewald, N. Barzilai, E. S. Gonos, et al.

    On October 28–31, 2024, there took place the international conference, “Longevity Nation 2024— Enhancing Research, Development and Education for Healthy Longevity” in Bar-Ilan University, Ramat Gan, Israel (http://www.longevitynation.org/). This conference explored the challenges that rise from population aging, from interdisciplinary perspectives that reflect new science and technology, and many social, cultural, political, economic and philosophical concerns that aging raises. By bringing together leading Israeli and international voices in the longevity space—researchers, developers, investors, educators, decision makers and public figures—the Longevity Nation conference aimed to contribute to increasing the synergy of science, technology and aging society, and help advance ethical scientific and technological solutions for healthy longevity for the benefit of the entire society. As the conference emphasized, in this period of conflict in Israel and the Middle East, it is especially important to build up international collaboration as a basis for future positive development.

  • Open Access

    Nucleic acid hybridization-based detection of pathogenic RNA using microscale thermophoresis

    by Matan Yosef Avivi, Noga Touitou, Hanan Rohana, Batia Lerrer, Yaron Shav-Tal, Avi Peretz, Haim Yosef Cohen


  • It is a branched road to adipose tissue aging

    by N. Touitou, B. Lerrer, H. Y. Cohen


  • The Cave of Horror: New Excavations in 2019

    by Ofer Sion, Eitan Klein, Amir Ganor, Uriah Amichai, Haim Cohen, Hagay Hamer

  • Open Access

    Hypothalamus–Muscle Parallel Induction of Metabolic Pathways Following Physical Exercise

    by Almog Katz, Meital Gonen, Yael Shahar, Asael Roichman, Batia Lerrer, Haim Yosef Cohen

    The modern lifestyle requires less physical activity and skills during our daily routine, leading to multiple pathologies related to physical disabilities and energy accessibility. Thus, exploring the mechanisms underlying the metabolic regulation of exercise is crucial. Here, we characterized the effect of forced and voluntary endurance exercises on three key metabolic signaling pathways, sirtuins, AMPK, and mTOR, across several metabolic tissues in mice: brain, muscles, and liver. Both voluntary and forced exercises induced AMPK with higher intensity in the first. The comparison between those metabolic tissues revealed that the hypothalamus and the hippocampus, two brain parts, showed different metabolic signaling activities. Strikingly, despite the major differences in the physiology of muscles and hypothalamic tissues, the hypothalamus replicates the metabolic response of the muscle in response to physical exercise. Specifically, muscles and hypothalamic tissues showed an increase and a decrease in AMPK and mTOR signaling, respectively. Overall, this study reveals new insight into the relation between the hypothalamus and muscles, which enhances the coordination within the muscle–brain axis and potentially improves the systemic response to physical activity performance and delaying health inactivity disorders.


  • Open Access

    Dynamic regulation of N6,2′-O-dimethyladenosine (m6Am) in obesity

    by Moshe Shay Ben-Haim, Yishay Pinto, Sharon Moshitch-Moshkovitz, Vera Hershkovitz, Nitzan Kol, Tammy Diamant-Levi, Michal Schnaider Beeri, Ninette Amariglio, Haim Y. Cohen, Gideon Rechavi

    The prevalent m6Am mRNA cap modification was recently identified as a valid target for removal by the human obesity gene FTO along with the previously established m6A mRNA modification. However, the deposition and dynamics of m6Am in regulating obesity are unknown. Here, we investigate the liver m6A/m methylomes in mice fed on a high fat Western-diet and in ob/ob mice. We find that FTO levels are elevated in fat mice, and that genes which lost m6Am marking under obesity are overly downregulated, including the two fatty-acid-binding proteins FABP2, and FABP5. Furthermore, the cellular perturbation of FTO correspondingly affect protein levels of its targets. Notably, generally m6Am- but not m6A-methylated genes, are found to be highly enriched in metabolic processes. Finally, we deplete all m6A background via Mettl3 knockout, and unequivocally uncover the association of m6Am methylation with increased mRNA stability, translation efficiency, and higher protein expression. Together, these results strongly implicate a dynamic role for m6Am in obesity-related translation regulation.


  • Open Access

    Restoration of energy homeostasis by SIRT6 extends healthy lifespan

    by A. Roichman, S. Elhanati, M. A. Aon, I. Abramovich, A. Di Francesco, Y. Shahar, M. Y. Avivi, M. Shurgi, A. Rubinstein, Y. Wiesner, et al.

    Aging leads to a gradual decline in physical activity and disrupted energy homeostasis. The NAD+-dependent SIRT6 deacylase regulates aging and metabolism through mechanisms that largely remain unknown. Here, we show that SIRT6 overexpression leads to a reduction in frailty and lifespan extension in both male and female B6 mice. A combination of physiological assays, in vivo multi-omics analyses and 13C lactate tracing identified an age-dependent decline in glucose homeostasis and hepatic glucose output in wild type mice. In contrast, aged SIRT6-transgenic mice preserve hepatic glucose output and glucose homeostasis through an improvement in the utilization of two major gluconeogenic precursors, lactate and glycerol. To mediate these changes, mechanistically, SIRT6 increases hepatic gluconeogenic gene expression, de novo NAD+ synthesis, and systemically enhances glycerol release from adipose tissue. These findings show that SIRT6 optimizes energy homeostasis in old age to delay frailty and preserve healthy aging.